Vikram Raghunathan - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Vikram Raghunathan

Showing results (21-30 of 26) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 26 results.

Thrombosis Research|September 30, 2021

Erythrocytosis and thromboembolic events in transgender individuals receiving gender-affirming testosteroneMichael Oakes, Asad Arastu, Catherine Kato, et al.

Blood Advances|June 17, 2025

Pralatrexate is effective in cytotoxic cutaneous T-cell lymphomasChristina Poh, Jenna M Voutsinas, Mazyar Shadman, et al.

British Journal of Haematology|September 11, 2025

Impact of immunophenotype on clinical disease characteristics and outcomes in T-cell prolymphocytic leukaemiaChristina Poh, Xueyan Chen, Jenna Voutsinas, et al.

Blood Advances|March 19, 2026

Real-World Evidence for Pembrolizumab Gemcitabine Vinorelbine and Liposomal Doxorubicin in Classical Hodgkin LymphomaGrace Baek, Gaurav Varma, Samuel Yamshon, et al.

Blood|February 12, 2025

Outcomes among adult recipients of CAR T-cell therapy for Burkitt lymphomaLaura Samples, Hossein Sadrzadeh, Matthew J Frigault, et al.

Blood|September 27, 2021

Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutionsVictor Manuel Orellana-Noia, Daniel R Reed, Ashley Alesia McCook, et al.

Pageof 3

Search research articles

Showing results (21-30 of 26) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 26 results.

Thrombosis Research|September 30, 2021

Erythrocytosis and thromboembolic events in transgender individuals receiving gender-affirming testosteroneMichael Oakes, Asad Arastu, Catherine Kato, et al.

Blood Advances|June 17, 2025

Pralatrexate is effective in cytotoxic cutaneous T-cell lymphomasChristina Poh, Jenna M Voutsinas, Mazyar Shadman, et al.

British Journal of Haematology|September 11, 2025

Impact of immunophenotype on clinical disease characteristics and outcomes in T-cell prolymphocytic leukaemiaChristina Poh, Xueyan Chen, Jenna Voutsinas, et al.

Blood Advances|March 19, 2026

Real-World Evidence for Pembrolizumab Gemcitabine Vinorelbine and Liposomal Doxorubicin in Classical Hodgkin LymphomaGrace Baek, Gaurav Varma, Samuel Yamshon, et al.

Blood|February 12, 2025

Outcomes among adult recipients of CAR T-cell therapy for Burkitt lymphomaLaura Samples, Hossein Sadrzadeh, Matthew J Frigault, et al.

Blood|September 27, 2021

Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutionsVictor Manuel Orellana-Noia, Daniel R Reed, Ashley Alesia McCook, et al.

Pageof 3